Volume 50 | August 2021

Cover Story

The prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing world wide, with nearly 1 billion people globally affected. This tremendous rise is related to the worldwide obesity and diabetes epidemics, which together represent a heavy clinical and economic burden on society. NAFLD ranges from simple steatosis to non-alcoholic steatohepatitis (NASH) with or without hepatic fibrosis in the absence of excessive alcohol intake. 

Full text



All Articles

Anja Zeigerer

Kalliopi Pafili, Michael Roden

Wenke Jonas, Annette Schürmann

Yang Xiao, Mindy Kim, Mitchell A. Lazar

Michael Shum, Jennifer Ngo, Orian S. Shirihai, Marc Liesa

Douglas G. Mashek

Joerg Heeren, Ludger Scheja

Dyonne Y. Vos, Bart van de Sluis

Beatriz Cicuéndez, Irene Ruiz-Garrido, Alfonso Mora, Guadalupe Sabio

Kendra K. Bence, Morris J. Birnbaum


Veeral Ajmera, Rohit Loomba

Maryam Mahjoubin-Tehran, Antonio De Vincentis, Dimitri P. Mikhailidis, Stephen L. Atkin, ... Amirhossein Sahebkar